You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Loss of MR 4

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor Trial in Philadelphia (Biopsy,

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Biopsy
  • +3 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Aug 5, 2022

Real-time Tumor Localization and Guidance for Radiotherapy Using

Recruiting
  • Tumor, Solid
  • 4D Planar US Transducer
  • Madison, Wisconsin
    University of Wisconsin, Madison
Nov 8, 2022

Clinical Phenotypic Characteristics of SC26A4

Recruiting
  • Hearing Loss
  • Pendred Syndrome
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Jul 24, 2023

    3T MR for Secondary Hyperparathyroidism Comparison With 4DCT

    Not yet recruiting
    • Parathyroid Gland Disease
    • Secondary Hyperparathyroidism
      • (no location specified)
      Sep 15, 2022

      Healthy Trial in Nottingham (Ref (TF2), Evobrutinib MR-T1, Evobrutinib MR-T2)

      Recruiting
      • Healthy
      • Ref (TF2)
      • +8 more
      • Nottingham, United Kingdom
        Quotient Clinical Ltd
      Jul 11, 2022

      Advanced Solid Tumors Trial in Guangzhou (MR001)

      Not yet recruiting
      • Advanced Solid Tumors
      • Guangzhou, Guangdong, China
        Nanfang Hospital, Southern Medical University
      Nov 12, 2023

      Weight Loss Trial in Sandy (Transform Burn)

      Completed
      • Weight Loss
      • Transform Burn
      • Sandy, Utah
        4Life Research
      Oct 16, 2023

      Hearing Loss, Sensorineural, Bilateral Vestibular Deficiency, DFNA9 Trial in Hasselt (video nystagmography)

      Recruiting
      • Hearing Loss, Sensorineural
      • +3 more
      • video nystagmography
      • Hasselt, Limburg, Belgium
        Jessa Hospital
      Mar 29, 2022

      Glioblastoma Multiforme Trial in Toronto (Reduced margin adaptive radiotherapy)

      Recruiting
      • Glioblastoma Multiforme
      • Reduced margin adaptive radiotherapy
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre
      Oct 19, 2022

      Sensorineural Hearing Loss, Bilateral, Bilateral Hearing Loss Trial in Saint-Étienne (FS4 then TFS4 (cochlear implant), TFS4

      Not yet recruiting
      • Sensorineural Hearing Loss, Bilateral
      • Bilateral Hearing Loss
      • FS4 then TFS4 (cochlear implant)
      • TFS4 then FS4 (cochlear implant)
      • Saint-Étienne, France
        CHU Saint-Etienne
      Jul 13, 2023

      Obesity, Diabetes, Metabolic Syndrome Trial in London (Semaglutide 3 mg, Placebo)

      Recruiting
      • Obesity
      • +2 more
      • Semaglutide 3 mg
      • Placebo
      • London, United Kingdom
        UCL
      Nov 3, 2022

      Uterine Cervical Tumors Trial in Toronto (Hyperpolarized 13C-Pyruvate, 18F-FDG)

      Terminated
      • Uterine Cervical Neoplasms
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre
      Sep 20, 2022

      Hearing Loss, Sensorineural, Bilateral Vestibular Deficiency, DFNA9 Trial in Hasselt (vestibular test 1, vestibular test 2,

      Recruiting
      • Hearing Loss, Sensorineural
      • +3 more
      • vestibular test 1
      • +5 more
      • Hasselt, Limburg, Belgium
        Jessa Hospital
      Aug 24, 2021

      Bone Loss Trial in Mansoura (PEEK framework)

      Completed
      • Bone Loss
      • PEEK framework
      • Mansoura, Egypt
        Khloud Ezzat
      Aug 27, 2023

      Brain Metastases Trial in Toronto (Hyperpolarized 13C-Pyruvate)

      Recruiting
      • Brain Metastases
      • Hyperpolarized 13C-Pyruvate
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre
      May 4, 2022

      Obesity Trial (Weighted vest)

      Suspended
      • Obesity
      • Weighted vest
      • Dublin, Ireland
        University College Dublin Clinical Research Centre
      Oct 10, 2022

      Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

      Withdrawn
      • Advanced Solid Tumor
      • +9 more
      • (no location specified)
      Oct 16, 2023

      Atrial Fibrillation, Obesity Trial in Calgary (CR with added BWLT)

      Recruiting
      • Atrial Fibrillation
      • Obesity
      • CR with added BWLT
      • Calgary, Alberta, Canada
        University of Calgary
      Oct 31, 2022

      Healthy, Obesity, Diabetes Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (MR Imaging

      Recruiting
      • Healthy
      • +4 more
      • MR Imaging Techniques - 1
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Bone Loss Trial in Mansoura (screw retained prosthesis)

      Completed
      • Bone Loss
      • screw retained prosthesis
      • Mansoura, Egypt
        Khloud Ezzat
      Oct 8, 2023

      Zoledronic Acid to Prevent Bone Loss Following Denosumab

      Recruiting
      • Osteoporosis
      • +3 more
      • Zoledronic acid
      • Calgary, Alberta, Canada
        University of Calgary, McCaig Institute for Bone and Joint Healt
      Nov 1, 2022

      A Scalp Lotion Toimprove Sensitive Scalp Syndrome

      Completed
      • Alopecia
      • Sensitive Skin
      • Piroctone Olamine (PO), 2,4 Diaminopyrimidine oxide (2.4 DA) and Vichy mineralizing water
      • Saint-Ouen, France
        L'OREAL Research and Innovation
      Nov 18, 2022

      Obesity, Obesity; Drug, Overweight or Obesity Trial in Loma Linda (Semaglutide 2.4mg, Placebo)

      Not yet recruiting
      • Obesity
      • +5 more
      • Semaglutide 2.4mg
      • Placebo
      • Loma Linda, California
        Loma Linda University Health
      Mar 24, 2022

      Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

      Not yet recruiting
      • Advanced Malignant Solid Neoplasm
      • +2 more
      • Biopsy
      • +5 more
      • (no location specified)
      Apr 8, 2023

      LANDMARC Study: a Study With Focus on Aorta Ascendens

      Not yet recruiting
      • Aortic Diseases
      • +5 more
      • 4D-flow MR & CT-scan
      • Maastricht, Limburg, Netherlands
        MaastrichtUMC
      Dec 16, 2022